Related Experiment Video
Updated: Jun 2, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
De novo designed proteins neutralize lethal snake venom toxins
Susana Vázquez Torres1,2,3, Melisa Benard Valle4, Stephen P Mackessy5
1Department of Biochemistry, University of Washington, Seattle, WA, USA.
Researchers developed novel, stable proteins using deep learning to neutralize dangerous three-finger toxins (3FTx) from snake venom. These engineered proteins offer a promising foundation for developing more effective and accessible antivenom treatments for snakebite envenoming.
Area of Science:
- Biochemistry
- Toxicology
- Computational Biology
Background:
- Snakebite envenoming is a neglected tropical disease causing over 100,000 deaths annually.
- Three-finger toxins (3FTx) are key venom components responsible for severe tissue damage and neurotoxicity.
- Current antivenom treatments are costly and have limited efficacy against 3FTxs.
Purpose of the Study:
- To design novel protein therapeutics targeting three-finger toxins (3FTx) using deep learning.
- To develop effective neutralizers for both neurotoxic and cytotoxic 3FTx subfamilies.
- To create a foundation for next-generation antivenom therapies.
Main Methods:
- De novo protein design utilizing deep learning algorithms.
- Computational modeling to predict protein structure and binding affinity.
- In vitro and in vivo assays to evaluate toxin neutralization and therapeutic efficacy in mice.
Main Results:
- Successfully designed stable proteins with high binding affinity for 3FTx.
- Demonstrated effective in vitro neutralization of all three 3FTx subfamilies.
- Achieved significant protection in mice against lethal neurotoxin challenge.
Conclusions:
- Deep learning-based protein design can yield potent and stable toxin-neutralizing agents.
- These engineered proteins represent a potential breakthrough for safer, cost-effective antivenom therapeutics.
- This approach could accelerate therapeutic discovery for neglected tropical diseases in resource-limited settings.
More Related Videos
12:16High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
Published on: July 30, 2014
10:25Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
Related Concept Videos
Cross-reactivity
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...